Skip to content

Search

Showing results for "Childhood interstitial lung disease "

Large-scale study of epigenetic landscape to understand and overcome diabetes in Indigenous Australians

A large-scale study of the epigenetic landscape of Indigenous Australians could help tackle chronic diseases faced by Aboriginal and Torres Strait Islander people.

World Breastfeeding Week: Q&A

In celebration of World Breastfeeding Week (1 – 7 August), we sat down with Professor Valerie Verhasselt to ask her some of the top questions about breastfeeding and immunology.

The Kids Research Institute Australia to lead international research team in tackling acute rheumatic fever

An international research team led by The Kids Research Institute Australia has been awarded a $5 million Synergy Grant by the NHMRC.

Researchers find new way to deliver ‘smart drugs’ for hard-to-treat diseases

Researchers from Perth’s The Kids Research Institute Australia have developed a world-first screening tool that helps deliver smart drugs into cells to battle hard-to-treat diseases like cancer and Duchenne Muscular Dystrophy.

Perth mums play instrumental part in world-first vaccine

New mothers in Perth are teaming up with researchers at The Kids Research Institute Australia in a global bid to develop the first vaccine to prevent Respiratory Syncytial Virus (RSV) disease.

$2 million grant to develop diagnostic tool for rheumatic fever

The Kids Research Institute Australia & Menzies School of Health Research will lead an international project to develop a diagnostic tool for acute rheumatic fever.

The Kids Research Institute Australia researcher wins Premier’s Science Award

Infectious diseases researcher, Dr Asha Bowen, has won the Early Career Scientist of the Year Premier's Science Award for 2017.

A new job for a specialised drug

The Kids is investigating whether a cystic fibrosis medication may be the answer to ear infections, reducing the need for antibiotics and surgery.

Characterisation of invasive Group B Streptococcus in Western Australian infants over a 15-year period

Christopher Blyth MBBS (Hons) DCH FRACP FRCPA PhD Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases

Safety and Immunogenicity of Early Quadrivalent Influenza Vaccine: A phase 2prospective randomised open-label feasibility study (FluBub)

Young children, particularly those younger than six (6) months are at increased riskof severe influenza infection.